Report Library
View More
Non-Small Cell Lung Cancer (NSCLC) ...
May 9, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 7, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 6, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 3, 2024
Melanoma KOL Interview - US, Midwes...
April 30, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Datamonitor Healthcare CV&Met Disea...
April 29, 2024
Datamonitor Healthcare I&I: Axial S...
April 29, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Melanoma KOL Interview - Germany
April 26, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/22/24 | Novo Nordisk (NVO) | Awiqli for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/21/24 | Highlight Therapeutics | BO-112 for Skin Cancer - Basal Cell Carcinoma (BCC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/21/24 | Rezolute (RZLT) | RZ402 for Diabetic Macular Edema (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/21/24 | Citius Pharmaceuticals (CTXR) | Mino-Lok for Catheter Complications | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/21/24 | GSK (GSK) | GSK3511294 for Asthma | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/19/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/09/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/18/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |